NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
29 hedge funds and large institutions have $2.76M invested in Navidea Biopharmaceuticals Inc. in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
29
Holding in Top 10
–
Calls
$250K
Puts
$619K
Top Buyers
| 1 | +$15.8K | |
| 2 | +$15K | |
| 3 | +$11K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$3.72K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.65K |
Top Sellers
| 1 | -$98.4K | |
| 2 | -$62.4K | |
| 3 | -$39.5K | |
| 4 |
ACM
Allred Capital Management
Dallas,
Texas
|
-$15.4K |
| 5 |
Morgan Stanley
New York
|
-$15.2K |